SK
Sumit Kumar
About Sumit Kumar
Data last updated:
Sumit Kumar is a Director at Vsaar Pharma Private Limited (since 2021), Director at Wagnerhuber Pharmaceuticals Private Limited (since 2019) and Director at Dcm Pharma Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹8.37 Cr; the largest is Vsaar Pharma Private Limited at ₹4.24 Cr (FY 2025). Earlier, Sumit Kumar was a Director at Proton Pharma Private Limited (2019–2025) and Director at D M Pharma Private Limited (2021–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Apr 2021 | 2012 | ₹4.24 Cr (FY 2025) | Active | |
| Director | 01 Nov 2019 | 2010 | ₹2.36 Cr (FY 2025) | Active | |
| Director | 13 May 2020 | 2020 | ₹1.07 Cr (FY 2024) | Active | |
| Whole-Time Director | 15 Mar 2021 | 2015 | ₹68.6 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Nov 2019 | 2012 | Active | ||
| Director | 20 Mar 2021 | 2012 | ₹79.75 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sumit Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Radhe Sham Goyal | 03166779 | Vsaar Pharma Private Limited , Alvizia Healthcare Private Limited | Director |
| Rakesh Kumar Rana | 05283002 | Vsaar Pharma Private Limited | Whole-Time Director |
| Ashwani Bhalla | 02989701 | Wagnerhuber Pharmaceuticals Private Limited | Director |
| Virender Kumar | 08097550 | Wagnerhuber Pharmaceuticals Private Limited | Whole-Time Director |
| Abhinav Aggarwal | 08741927 | Dcm Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumit Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumit Kumar
Sumit Kumar currently holds 4 directorships: Vsaar Pharma Private Limited (Director, since 21 Apr 2021, revenue ₹4.24 Cr (FY 2025)); Wagnerhuber Pharmaceuticals Private Limited (Director, since 01 Nov 2019, revenue ₹2.36 Cr (FY 2025)); Dcm Pharma Private Limited (Director, since 13 May 2020, revenue ₹1.07 Cr (FY 2024)); Alvizia Healthcare Private Limited (Whole-Time Director, since 15 Mar 2021, revenue ₹68.6 Lakh (FY 2025)).
Sumit Kumar was first appointed on 01 Nov 2019 as Director at Wagnerhuber Pharmaceuticals Private Limited. The most recent appointment on record is 21 Apr 2021 at Vsaar Pharma Private Limited.
The 4 current companies of Sumit Kumar that report revenue have a combined latest revenue of ₹8.37 Cr: Vsaar Pharma Private Limited ₹4.24 Cr (FY 2025); Wagnerhuber Pharmaceuticals Private Limited ₹2.36 Cr (FY 2025); Dcm Pharma Private Limited ₹1.07 Cr (FY 2024); Alvizia Healthcare Private Limited ₹68.6 Lakh (FY 2025).
Sumit Kumar held 2 earlier board appointments: Proton Pharma Private Limited (Director, 01 Nov 2019 to 18 Jul 2025); D M Pharma Private Limited (Director, 20 Mar 2021 to 18 Jul 2025).
The current boards of Sumit Kumar's companies include Radhe Sham Goyal (Vsaar Pharma Private Limited), Rakesh Kumar Rana (Vsaar Pharma Private Limited), Ashwani Bhalla (Wagnerhuber Pharmaceuticals Private Limited), Virender Kumar (Wagnerhuber Pharmaceuticals Private Limited), Abhinav Aggarwal (Dcm Pharma Private Limited).